S. Rosenberg

发表

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

James Allison, Stephen Forman, Massimo Cristofanilli, 2015, Mayo Clinic proceedings.

The natural history of initially untreated low-grade non-Hodgkin's lymphomas.

S. Horning, S. Rosenberg, S J Horning, 1984, The New England journal of medicine.

Human interferon alpha in malignant lymphoma and Hodgkin's disease. Results of the american cancer society trial

T. Merigan, S. Horning, F. Cabanillas, 1985, Cancer.

Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: evidence of in vivo priming by tumor cells.

M. Salgaller, F. Marincola, L. Rivoltini, 1996, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy.

F. Marincola, S. Topalian, J. Cormier, 1998, Journal of immunotherapy.

Hodgkin's disease: Current recommendations for management

H. Kaplan, S. Rosenberg, 1975, CA: a cancer journal for clinicians.

Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro.

J. Cormier, N. Restifo, F. Marincola, 1997, Journal of immunotherapy.

Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides.

M. Salgaller, Y. Kawakami, F. Marincola, 1995, Cancer research.

Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression.

S. Steinberg, S. Migueles, M. Connors, 1999, Journal of immunology.

Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy.

R. Advani, S. Horning, S. Rosenberg, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Computed tomography, lymphography, and staging laparotomy: correlations in initial staging of Hodgkin disease.

R. Castellino, R. Hoppe, H. Kaplan, 1984, AJR. American journal of roentgenology.

History of Radiotherapy of Hodgkin’s Disease (Now Hodgkin Lymphoma)

L. Specht, S. Rosenberg, 2011 .

Lymphography: a great advance, abandoned.

S. Rosenberg, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-Term Outcomes of Patients with Early-Stage Non-Bulky Hodgkin Lymphoma Treated with Combined Modality Therapy on the Stanford V Trials (The G4 and G5 Studies).

R. Advani, R. Von Eyben, R. Hoppe, 2020, International journal of radiation oncology, biology, physics.

Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience.

R. Advani, S. Horning, R. Hoppe, 2011, International journal of radiation oncology, biology, physics.

Follicular lymphoma revisited.

S. Rosenberg, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CEPP(B): an effective and well-tolerated regimen in poor-risk, aggressive non-Hodgkin's lymphoma

S. Horning, N. Chao, S. Rosenberg, 1990 .

CEPP(B): an effective and well-tolerated regimen in poor-risk, aggressive non-Hodgkin's lymphoma.

N. Chao, S. Rosenberg, S. J. Horning, 1990, Blood.

Late relapse from complete remission in nodular and diffuse histiocytic lymphoma

G. Mead, S. Rosenberg, J. S. Burke, 1983, Cancer.

Treatment of Primary Neoplasms of Lymphoid Tissues

S. Rosenberg, 1978 .

Non‐Hodgkin's lymphomas. II. Single agent chemotherapy

S. Jones, R. Dorfman, H. Kaplan, 1972, Cancer.

Combined modality therapy in malignant lymphomas.

S. Donaldson, H. Kaplan, S. Rosenberg, 1977, Cancer treatment reports.

Staging laparotomies in unselected previously untreated patients with non‐Hodgkin's lymphomas

R. Castellino, Z. Fuks, D. Goffinet, 1973, Cancer.

Autologous bone marrow transplantation in non-Hodgkin's lymphoma.

S. Rosenberg, 1987, The New England journal of medicine.

Changing Concepts in Therapy of the Non-Hodgkin Lymphomas

S. Rosenberg, 1985 .

Clinical Manifestations, Staging, and Management of the Non-Hodgkin’s Lymphomas: An Overview

S. Rosenberg, 1980 .

Efficacy of Abbreviated Stanford V Chemotherapy and Involved Field Radiotherapy in Early Stage Hodgkin's Disease: Mature Results of the G4 Trial.

R. Advani, S. Horning, R. Hoppe, 2009 .

Efficacy and Late Effects of Stanford V Chemotherapy and Radiotherapy in Untreated Hodgkin’s Disease: Mature Data in Early and Advanced Stage Patients.

R. Warnke, R. Advani, S. Horning, 2004 .

Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens.

E. Wang, U. Kammula, G. A. Ohnmacht, 1999, Journal of immunology.

Report of the Committee on Hodgkin's Disease Staging Procedures.

V. Devita, M. Boiron, J. Ultmann, 1971, Cancer research.

The continuing challenge of Hodgkin's disease.

S. Rosenberg, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy.

W. Travis, S. Rosenberg, J. McIntosh, 1990, Cancer research.

Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides.

J. Cormier, M. Salgaller, F. Marincola, 1996, Cancer research.

Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1.

M. Gonda, V. Hearing, J. Tupesis, 1997, Journal of immunological methods.

Hematologic neoplasia in patients treated for Hodgkin's disease.

E. Glatstein, H. Kaplan, A. Flint, 1977, The New England journal of medicine.

The value of laparotomy and splenectomy in the staging of Hodgkin's disease

E. Glatstein, H. Kaplan, S. Rosenberg, 1969, Cancer.

Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas.

R. Warnke, R. Castellino, D. Goffinet, 1977, Cancer treatment reports.

Immune selection after antigen-specific immunotherapy of melanoma.

S. Steinberg, F. Marincola, S. Rosenberg, 1999, Surgery.

Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions.

P. Duray, M. Herlyn, J. Cormier, 1996, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment

E. Glatstein, H. Kaplan, S. Rosenberg, 1976, Cancer.

Laser Scanning Cytometry Evaluation of MART-1, gp100, and HLA-A2 Expression in Melanoma Metastases

F. Marincola, S. Rosenberg, S. Mocellin, 2001, Journal of immunotherapy.

Surgical staging of abdominal involvement in unselected patients with Hodgkin's disease.

E. Glatstein, H. Kaplan, S. Rosenberg, 1970, Radiology.

Hodgkin's disease of the bone marrow.

S. Rosenberg, 1971, Cancer research.

Clinical course and management of accidental adriamycin extravasation

S. Rosenberg, J. Reilly, S. Rosenberg, 1977, Cancer.

The management of Hodgkin's disease: half a century of change. The Kaplan Memorial Lecture.

S. Rosenberg, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: advances in the monitoring of patients with metastatic melanoma.

E. Wang, P. Fetsch, A. Abati, 1999, Cancer detection and prevention.

Myocarditis or acute myocardial infarction associated with interleukin‐2 therapy for cancer

W. Travis, W. Roberts, S. Rosenberg, 1990, Cancer.

A STUDY OF THE ETIOLOGICAL BASIS OF PRIMARY PULMONARY HYPERTENSION.

S. Rosenberg, 1964, American heart journal.

Hodgkin's disease: challenges for the future.

S. Rosenberg, 1989, Cancer research.

Role of FDG-PET/CT Surveillance for Patients with Classical Hodgkin's Disease in First Complete Response: The Stanford University Experience.

R. Advani, A. Iagaru, S. Horning, 2009 .

Current concepts in cancer: non-Hodgkin's lymphoma--selection of treatment on the basis of histologic type.

S. Rosenberg, 1979, The New England journal of medicine.

necrosis factor-alpha in response to autologous tumor stimulation secrete granulocyte-macrophage colony-stimulating factor and tumor Tumor-infiltrating lymphocytes derived from select B-cell lymphomas

S. Topalian, M. Stetler-Stevenson, D. Schwartzentruber, 2011 .

Non‐Hodgkin's lymphomas. VI. Results of treatment in childhood

S. Donaldson, E. Glatstein, R. Dorfman, 1974, Cancer.

Clinical aspects of non‐Hodgkin's lymphomas presenting with discordant histologic subtypes

G. Mead, S. Rosenberg, J. Burke, 1983, Cancer.

Non‐Hodgkin's lymphomas. I. Bone marrow involvement

S. Jones, H. Kaplan, S. Rosenberg, 1972, Cancer.

Long-term outcomes of patients with unfavorable stage I–II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation

R. Advani, R. Von Eyben, R. Hoppe, 2020, Leukemia & lymphoma.

The Results of the Treatment of Hodgkin’s Disease: An Overview of Current Approaches and Future Directions

S. Rosenberg, 1980 .

Pediatric Hodgkin's disease. II. Results of therapy

S. Donaldson, E. Glatstein, H. Kaplan, 1976 .

Reducing the toxicity of the combined modality therapy of favourable stage Hodgkin's disease.

S. Rosenberg, 1992, European journal of cancer.

The low grade non-Hodgkin’s lymphomas: Current approaches to therapy

S. Rosenberg, 1985 .

The effect of intravenous interleukin-2 on brain water content.

N. Patronas, E. Oldfield, D. Schwartzentruber, 1989, Journal of neurosurgery.

Correction: Deaths after Treatment of Hodgkin Disease

S. Hancock, R. Cox, S. Rosenberg, 1991 .

The treatment of Hodgkin's disease.

S. Rosenberg, H. Kaplan, 1966, The Medical clinics of North America.

The treatment of Hodgkin's disease.

H. Kaplan, S. Rosenberg, 1966, The Medical clinics of North America.

Comparative studies of the long-term growth of lymphocytes from tumor infiltrates, tumor-draining lymph nodes, and peripheral blood by repeated in vitro stimulation with autologous tumor.

S. Topalian, Y. Skornick, S. Rosenberg, 1990, Journal of Biological Response Modifiers.

Pathology of malignant lymphomas in the liver: application in staging.

R. Dorfman, S. Rosenberg, H. Kim, 1976, Progress in liver diseases.

Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus antigens in patients with Epstein-Barr virus-negative Hodgkin's disease.

R. Advani, H. Kohrt, S. Horning, 2009, Oncology research.

Lymphomas involving the gastrointestinal tract

H. Herzenberg, G. M. Gray, S. Rosenberg, 1982 .

The value of sequential bone marrow biopsy and laparotomy and splenectomy in a series of 200 consecutive untreated patients with non-Hodgkin's lymphoma.

S. Rosenberg, M. Ribas-Mundó, M. Ribas‐Mundo, 1979, European journal of cancer.

The value of sequential bone marrow biopsy and laparotomy and splenectomy in a series of 127 consecutive untreated patients with non-Hodgkin's lymphoma.

R. Dorfman, H. Kaplan, S. Rosenberg, 1975, The British journal of cancer. Supplement.

The management of Hodgkin's disease

H. Kaplan, S. Rosenberg, 1975, Cancer.

Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support.

R. Warnke, R. Advani, S. Rosenberg, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Management of the pregnant patient with Hodgkin's disease.

S. Donaldson, C. Jacobs, H. Kaplan, 1981, Annals of internal medicine.

Infections in patients with Hodgkin's disease: a clinical study of 300 consecutive adult patients.

J. Remington, S. Rosenberg, D. Notter, 1980, Reviews of infectious diseases.

Non‐Hodgkin's lymphomas. V. Results of radiotherapy

Z. Fuks, S. Jones, H. Kaplan, 1973, Cancer.

Evidence for an orderly progression in the spread of Hodgkin's disease.

H. Kaplan, S. Rosenberg, 1966, Cancer research.

Diffuse histiocytic lymphoma presenting with gastrointestinal tract lesions the stanford experience

S. Rosenberg, F. Rosenfelt, 1980, Cancer.

Combined modality therapy of Hodgkin's disease. A report on the stanford trials

E. Glatstein, H. Kaplan, S. Rosenberg, 1978, Cancer.

Treatment of advanced Hodgkin's disease with B‐CAVe following MOPP failure

S. Rosenberg, C. Portlock, K. J. Porzig, 1978, Cancer.

The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy

H. Kaplan, S. Rosenberg, 1975, Cancer.

Intratumoral LAK cell and interleukin-2 therapy of human gliomas.

E. Oldfield, D. Barba, S. Rosenberg, 1989, Journal of neurosurgery.

The grading of soft tissue sarcomas results of a clinicohistopathologic correlation in a series of 163 cases

S. Rosenberg, E. Glatstein, R. Wesley, 1984, Cancer.

Report of the Committee on the Staging of Hodgkin's Disease

S. Rosenberg, 1966 .

The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.

H. Kaplan, S. Rosenberg, 1984, International journal of radiation oncology, biology, physics.

Spontaneous regression of non‐Hodgkin's lymphoma: A report of nine cases

D. P. Cooney, S. Rosenberg, C. Portlock, 1980, Cancer.

Extended-field radical radiotherapy in advanced Hodgkin's disease: short-term results of 2 randomized clinical trials.

H. Kaplan, S. Rosenberg, 1966, Cancer Research.

Central nervous system involvement in non‐Hodgkin's lymphoma: An analysis of 105 cases

T. Colby, R. Hoppe, H. Kaplan, 1982, Cancer.

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

M Tubiana, D Crowther, E Glatstein, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types).

C. Coleman, R. Dorfman, S. Rosenberg, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.

R. Advani, S. Horning, P. Greenberg, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single agent palliative chemotherapy for end‐stage Hodgkin's disease

S. Rosenberg, G. Mead, W. G. Harker, 1982, Cancer.

A critique of the value of laparotomy and splenectomy in the evaluation of patients with Hodgkin's disease.

S. Rosenberg, 1971, Cancer research.

Lymphoblastic lymphoma in adults: results of a pilot protocol.

S. Rosenberg, J. Cohen, J. S. Burke, 1981, Blood.

The Low-Grade Non-Hodgkin's Lymphomas: Challenges and Opportunities

S. Rosenberg, 1985 .

Laparotomy and splenectomy in Hodgkin's disease: a reappraisal after twenty years.

S. Rosenberg, 2009, Scandinavian journal of haematology.

Malignant Lymphomas: Etiology, Immunology, Pathology, Treatment

H. Kaplan, S. Rosenberg, 1982 .

Prognostic factors in pathological stage IIIA Hodgkin's disease

R. Hoppe, H. Kaplan, R. Cox, 1980, Cancer.

Staging laparotomy and splenectomy in Hodgkin's disease: analysis of indications and patterns of involvement in 285 consecutive, unselected patients.

R. Dorfman, H. Kaplan, H S Kaplan, 1973, National Cancer Institute monograph.

The management of Hodgkin's disease.

S. Rosenberg, 1978, The New England journal of medicine.

combined modality therapy: the Stanford experience The management of stage I--II Hodgkin's disease with irradiation alone or

R. Hoppe, H. Kaplan, R. Cox, 2011 .

Histologic conversion in the non-Hodgkin's lymphomas.

T. Colby, R. Hoppe, H. Kaplan, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non‐hodgkin's lymphomas iv. clinicopathologic correlation in 405 cases

Z. Fuks, S. Jones, R. Dorfman, 1973, Cancer.

The Paris conference "La Radiothérapie de la Maladie de Hodgkin": a first step in the cure of Hodgkin disease.

R. Hoppe, S. Rosenberg, 2015, International journal of radiation oncology, biology, physics.

Treatment of Hodgkin lymphoma: a 50-year perspective.

J. Friedberg, T. Lister, V. Devita, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Staging in adult non-Hodgkin's lymphomas.

D. Goffinet, H. Kaplan, S. Rosenberg, 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Treatment of advanced non-Hodgkin's lymphomas with favorable histologies: preliminary results of a prospective trial

E. Glatstein, H. Kaplan, S. Rosenberg, 1976 .

Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in advanced non‐Hodgkin's lymphomas

S. Rosenberg, C. Portlock, Carol S. Portlock, 1976, Cancer.

Clinical trials in the non-Hodgkin's lymphomata at Stanford University experimental design and preliminary results.

H. Kaplan, S. Rosenberg, 1975, The British journal of cancer. Supplement.

A summary of the results of a review of 405 patients with non-Hodgkin's lymphoma at Stanford University.

R. Dorfman, H. Kaplan, S. Rosenberg, 1975, The British journal of cancer. Supplement.

Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

S. Rosenberg, C. Portlock, L. Elias, 1978, Cancer.

Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A.

F. Marincola, S. Rosenberg, J. Cormier, 1997, The cancer journal from Scientific American.

MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients

J. Bull, S. Jones, Melvin Moore, 1973, Cancer.

Analysis of non‐Hodgkin's lymphomas with nodular and favorable histologies, stages I and II

T. Colby, R. Hoppe, H. Kaplan, 1983, Cancer.

Cure of Hodgkin's disease and other malignant lymphomas.

H. Kaplan, S. Rosenberg, 1968, Postgraduate medicine.

Penetration of recombinant interleukin-2 across the blood-cerebrospinal fluid barrier.

E. Oldfield, D. Barba, S. Rosenberg, 1988, Journal of neurosurgery.

Combination chemotherapy and radiotherapy for Hodgkin's disease

J. Bull, S. Jones, H. Kaplan, 1972, Cancer.

Hodgkin's disease and other malignant lymphomas.

H. Kaplan, S. Rosenberg, 1970, California medicine.

Treatment of lymphoblastic lymphoma in adults.

L. Weiss, V. Picozzi, R. Cox, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience.

Summer S. Han, R. Warnke, Y. Natkunam, 2013, Blood.

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial.

S. Horning, B. W. Brown, N. Bartlett, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial.

S. Horning, B. W. Brown, R. Hoppe, 2001, Blood.

Biased epitope selection by recombinant vaccinia-virus (rVV)-infected mature or immature dendritic cells

F. Marincola, M. Panelli, S. Finkelstein, 2003, Gene Therapy.

Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.

R. Advani, P. Lavori, S. Horning, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rare presentation of classical Hodgkin lymphoma with a clonal T-cell receptor gene rearrangement in the tissue

Tudung T Nguyen, R. Warnke, D. Arber, 2010, Leukemia & lymphoma.

Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination.

F. Marincola, P. Fetsch, A. Abati, 1998, Journal of immunology.

Extralymphatic Hodgkin's disease. Prognosis and response to therapy.

F. Torti, H. Kaplan, S. Rosenberg, 1981, American Journal of Medicine.

Non-Hodgkin's lymphomas. 3. Preliminary results of radiotherapy and a proposal for new clinical trials.

S. Jones, H. Kaplan, S. Rosenberg, 1972, Radiology.

Extralymphatic involvement in diffuse non-Hodgkin's lymphoma.

R S Cox, P Sneed, R. Hoppe, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lymphomas involving the gastrointestinal tract.

H. Herzenberg, G. M. Gray, S. Rosenberg, 1982, Gastroenterology.

Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy

S. Rosenberg, C. Portlock, J. Krikorian, 1978, Cancer.

Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination.

F. Marincola, S. Rosenberg, U. Kammula, 2000, Journal of the National Cancer Institute.

Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease

R. Hoppe, E. Glatstein, H. Kaplan, 1979, Cancer.

Hodgkin's disease, stages I and II occurring below the diaphragm

S. Rosenberg, C. Portlock, J. Krikorian, 1979, Cancer.

A prospective trial of involved field radiation (IFRT) + chemotherapy compared to extended field (EFRT) radiation for favorable Hodgkin disease: Survival differences and implications of mature follow-up for current combined modality therapy

R. Advani, S. Hancock, S. Horning, 2007 .

Initial relapse in previously treated Hodgkin's disease--II retrograde transdiaphragmatic extension.

R. Castellino, E. Glatstein, H. Kaplan, 1977, International journal of radiation oncology, biology, physics.

The Clinical Evaluation and Staging of Patients with Malignant Lymphoma

S. Rosenberg, 1971 .

Hemodynamic effects of the administration of tumor-infiltrating lymphocytes to cancer patients.

F. Marincola, S. Topalian, D. Parkinson, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Karnofsky memorial lecture. The low-grade non-Hodgkin's lymphomas: challenges and opportunities.

S. Rosenberg, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Management of the Pregnant Patient with Hodgkinʼs Disease

S. Donaldson, C. Jacobs, H. Kaplan, 1982 .

The bcl-2 gene, follicular lymphoma, and Hodgkin's disease.

M. Cleary, S. Rosenberg, 1990, Journal of the National Cancer Institute.

Splenectomy In The Management Of Hodgkin's Disease

S. Rosenberg, 1972, British journal of haematology.

Hodgkin's disease limited to intrathoracic sites

R. Hoppe, Douglas Johnson, H. Kaplan, 2006, Cancer.

Place of Splenectomy in Evaluation and Management

S. Rosenberg, 1972 .

Splenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease: diagnostic and therapeutic challenges

R. Advani, D. Bingham, J. Brody, 2006, Annals of Hematology.

Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy.

R. Advani, E. Moding, R. Hoppe, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Exploratory laparotomy and splenectomy for Hodgkin's disease: a commentary.

S. Rosenberg, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Modern combined modality management of Hodgkin's disease

S. Rosenberg, 1994, Current Opinion in Oncology.

Abbreviated 8-week chemotherapy (CT) plus involved node radiotherapy (INRT) for nonbulky stage I-II Hodgkin lymphoma: Preliminary results of the Stanford G5 Study.

R. Advani, S. Horning, S. Rosenberg, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma

R. Advani, B. Daniel, D. Ikeda, 2016, American journal of clinical oncology.

Pediatric hodgkin's disease. II. Results of therapy.

S. Donaldson, E. Glatstein, H. Kaplan, 1976, Cancer.

The current status of the Stanford randomized clinical trials of the management of Hodgkin’s disease

S. Rosenberg, 1985 .

Survival in Follicular Lymphoma: The Stanford Experience, 1960–2003.

R. Tibshirani, R. Warnke, Y. Natkunam, 2007 .

Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver.

D. Fraker, S. Rosenberg, H. Alexander, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pediatric Hodgkin's disease. II. Results of therapy

S. Donaldson, E. Glatstein, H. Kaplan, 1976, Cancer.

Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials.

S. Hancock, S. Horning, S. Rosenberg, 1988, Annals of internal medicine.

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

R. Fisher, S. Rosenberg, M. Sznol, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy.

M. Kaminski, C. Coleman, S. Rosenberg, 1986, Annals of internal medicine.

Treatment of advanced non-Hodgkin's lymphomas with favorable histologies: preliminary results of a prospective trial.

S. Rosenberg, E. Glatstein, H. Kaplan, 1976, Blood.

Non-Hodgkin's Lymphomas

S. Jones, H. Kaplan, S. Rosenberg, 1972 .

Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.

S. Rosenberg, W. G. Harker, S. Rosenberg, 1984, Annals of internal medicine.

Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease.

S. Horning, S. Rosenberg, J. Halpern, 1997, Blood.

Complete axillary lymph node dissection for stage I-II carcinoma of the breast.

S. Rosenberg, M. Lippman, A. Lichter, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience.

S. Rosenberg, R. Hoppe, H. Kaplan, 1982, Blood.

Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial.

R. Warnke, R. Advani, S. Horning, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.

S. Hancock, S. Horning, S. Rosenberg, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation.

S. Hancock, S. Horning, S. Rosenberg, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of computed and conventional whole lung tomography in detecting pulmonary nodules: a prospective radiologic-pathologic study.

J. Doppman, A. Chang, S. Rosenberg, 1978, AJR. American journal of roentgenology.

The role of chemotherapy in the management of early stage Hodgkin's disease

S. Rosenberg, 1984, Hematological oncology.

Impact of salvage treatment on initial relapses in patients with Hodgkin disease, stages I-III.

S. Rosenberg, E. Glatstein, H. Kaplan, 1978, Blood.

Extended-field radiation therapy in Hodgkin's disease. A progress report.

H. Kaplan, S. Rosenberg, M. Bagshaw, 1968, Radiologic clinics of North America.

Bone marrow involvement in the non-Hodgkin's lymphomata.

S. Rosenberg, 1975, The British journal of cancer. Supplement.

A rare type of Hodgkin's disease.

S. Rosenberg, 1973, The New England journal of medicine.

Cutaneous malignant melanoma after Hodgkin's disease.

C. N. Coleman, W. Clark, C. Coleman, 1985, Annals of internal medicine.

Medical Oncology: Basic Principles and Clinical Management of Cancer

P. Schein, P. Calabresi, S. Rosenberg, 1993 .

Current concepts in cancer: non-Hodgkin's lymphoma--selection of treatment on the basis of histologic type.

S. Rosenberg, 1979, The New England journal of medicine.